During life, bone is being constantly resorbed and reformed in a process known as bone remodeling. Any disturbance in this process can result in bone diseases such as osteopetrosis and osteoporosis. The osteoclast is the bone cell responsible for resorption of the bone matrix. The mechanism by which these cells are stimulated to resorb bone is not known. Metabolites of the 5-lipoxygenase pathway have been shown to stimulate osteoclasts to resorb bone in a number of in vitro and in vivo bone resorbing systems, and could be responsible for bone loss due to inflammatory bone disease. During osteoclast ontogeny, the osteoclast precursor proliferates, differentiates and fuses to form a multinucleated cell, the mature osteoclast, which is capable of resorbing bone. The present studies were initiated to determine where in the osteoclast differentiation pathway 5-lipoxygenase metabolites are acting. The peptidoleukotrienes appear to have direct effects on mature osteoclasts, however, leukotriene B4, another metabolite of this pathway, appears to be having more dramatic effect on osteoclast precursors. LTB4 was found to be a fusogen which causes the osteoclast precursors to fuse to form multinucleated cells. Experiments were initiated to determine if inhibitors of the 5-lipoxygenase pathway would block the formation of osteoclasts. An inhibitor called ZM230,487 was found to be a potent inhibitor of osteoclast formation. This specific inhibitor of the 5-lipoxygenase enzyme binds to the enzyme in a chiral fashion to the active site. However, the non-specific 5-LO inhibitor nordihydroguaiaretic acid had no effect on osteoclast formation. These preliminary results suggest that the mechanism of action of ZM230,487 on decreasing osteoclast formation may not be via the 5-lipoxygenase pathway.

Agency
National Institute of Health (NIH)
Institute
National Institute of Dental & Craniofacial Research (NIDCR)
Type
Unknown (K16)
Project #
2K16DE000152-11
Application #
5210011
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
11
Fiscal Year
1996
Total Cost
Indirect Cost
Lyles, Mark B; Cameron, Ivan L (2002) Caffeine and other xanthines as cytochemical blockers and removers of heterocyclic DNA intercalators from chromatin. Cell Biol Int 26:145-54
Lyles, Mark B; Cameron, Ivan L (2002) Interactions of the DNA intercalator acridine orange, with itself, with caffeine, and with double stranded DNA. Biophys Chem 96:53-76
Lyles, M B; Cameron, I L; Rawls, H R (2001) Structural basis for the binding affinity of xanthines with the DNA intercalator acridine orange. J Med Chem 44:4650-60
Flynn, M A; Qiao, M; Garcia, C et al. (1999) Avian osteoclast cells are stimulated to resorb calcified matrices by and possess receptors for leukotriene B4. Calcif Tissue Int 64:154-9
Dongari-Bagtzoglou, A I; Ebersole, J L (1998) Increased presence of interleukin-6 (IL-6) and IL-8 secreting fibroblast subpopulations in adult periodontitis. J Periodontol 69:899-910
Novak, K F; Lee, L N; LeBlanc, D J (1998) Functional analysis of pVT745, a plasmid from Actinobacillus actinomycetemcomitans. Oral Microbiol Immunol 13:124-8
Dongari-Bagtzoglou, A I; Warren, W D; Berton, M T et al. (1997) CD40 expression by gingival fibroblasts: correlation of phenotype with function. Int Immunol 9:1233-41
Dongari-Bagtzoglou, A I; Ebersole, J L (1996) Gingival fibroblast cytokine profiles in Actinobacillus actinomycetemcomitans-associated periodontitis. J Periodontol 67:871-8
Kolodrubetz, D; Spitznagel Jr, J; Wang, B et al. (1996) cis Elements and trans factors are both important in strain-specific regulation of the leukotoxin gene in Actinobacillus actinomycetemcomitans. Infect Immun 64:3451-60
Dongari-Bagtzoglou, A I; Ebersole, J L (1996) Production of inflammatory mediators and cytokines by human gingival fibroblasts following bacterial challenge. J Periodontal Res 31:90-8

Showing the most recent 10 out of 34 publications